Bank Of Montreal Sellas Life Sciences Group, Inc. Transaction History

Bank Of Montreal

  • $197 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$5.36 - $9.53 $590,629 - $1.05 Million
-110,192 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$8.21 - $10.53 $7,471 - $9,582
910 Added 0.83%
110,192 $1.08 Million
Q2 2021

Aug 12, 2021
BUY
$7.19 - $13.71 $785,737 - $1.5 Million
109,282 New
109,282 $1.43 Million

Others Institutions Holding SLS

# of Institutions
37
Shares Held
4.37M
Call Options Held
3.28M
Put Options Held
56.3K
View Full List

About SELLAS Life Sciences Group, Inc.

SLS Quotes by TradingView
  • Ticker SLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,551,900
  • Market Cap $24.7M
  • Description
  • SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...
More about SLS
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email